Graft-versus-host disease after a blood and marrow transplantGGraft-versus-host disease after a blood and marrow transplantGraft-versus-host disease after a blood and marrow transplantEnglishHaematology;Immunology;OncologyChild (0-12 years);Teen (13-18 years)BodyImmune systemConditions and diseasesAdult (19+)NA2010-03-06T05:00:00ZJohn Doyle, MD, FRCPC, FAAPChristine Armstrong, RN, MScN, NP Peds8.0000000000000062.0000000000000761.000000000000Flat ContentHealth A-Z<p>Learn about how graft-versus-host disease is prevented and treated, after an allogeneic transplant.</p><p>After an allogeneic blood and marrow transplant (BMT), some children may develop a common complication, called graft vs host disease (GVHD).</p><h2>Key points</h2><ul><li>Graft vs host disease (GVHD) occurs when the new bone marrow stem cells recognize your child as different from what they expect.</li><li>Acute GVHD develops early after the transplant, while chronic GVHD develops later.</li><li>Children who develop GVHD usually take a combination of medicines including prednisone, cyclosporine, and methotrexate.</li></ul>
Maladie du greffon contre l’hôte après une greffe de sang et de moelle osseuseMMaladie du greffon contre l’hôte après une greffe de sang et de moelle osseuseGraft-versus-host disease after a blood and marrow transplantFrenchHaematology;Immunology;OncologyChild (0-12 years);Teen (13-18 years)BodyImmune systemConditions and diseasesAdult (19+)NA2010-03-06T05:00:00ZJohn Doyle, MD, FRCPC, FAAPChristine Armstrong, RN, MScN, NP Peds8.0000000000000062.0000000000000761.000000000000Flat ContentHealth A-Z<p>Apprendrez comment on prévient et traite la maladie du greffon contre l’hôte après une greffe allogénique.</p><p>Après une greffe de sang et de moelle osseuse allogénique (GSM), certains enfants pourraient développer une complication fréquente, appelée maladie du greffon contre l’hôte (MGCH).</p><h2>À retenir</h2><ul><li>La maladie du greffon contre l’hôte (MGCH) survient quand les nouvelles cellules souches de la moelle osseuse reconnaissent votre enfant (l’hôte) en tant qu’élément différent de ce à quoi elles s’attendent.</li><li>Une MGCH aiguë se développe tôt après la greffe alors qu’une MGCH chronique se développe plus tard.</li><li>Les enfants qui développent une MGCH prennent habituellement une combinaison de médicaments, notamment la prednisone, la cyclosporine et le méthotrexate.</li></ul>

 

 

Graft-versus-host disease after a blood and marrow transplant1555.00000000000Graft-versus-host disease after a blood and marrow transplantGraft-versus-host disease after a blood and marrow transplantGEnglishHaematology;Immunology;OncologyChild (0-12 years);Teen (13-18 years)BodyImmune systemConditions and diseasesAdult (19+)NA2010-03-06T05:00:00ZJohn Doyle, MD, FRCPC, FAAPChristine Armstrong, RN, MScN, NP Peds8.0000000000000062.0000000000000761.000000000000Flat ContentHealth A-Z<p>Learn about how graft-versus-host disease is prevented and treated, after an allogeneic transplant.</p><p>After an allogeneic blood and marrow transplant (BMT), some children may develop a common complication, called graft vs host disease (GVHD).</p><h2>Key points</h2><ul><li>Graft vs host disease (GVHD) occurs when the new bone marrow stem cells recognize your child as different from what they expect.</li><li>Acute GVHD develops early after the transplant, while chronic GVHD develops later.</li><li>Children who develop GVHD usually take a combination of medicines including prednisone, cyclosporine, and methotrexate.</li></ul><p>GVHD occurs when the new bone marrow stem cells, called the graft, recognize your child (the host) as different from what they expect. The graft contains donor white blood cells called lymphocytes, which distinguish between cells that belong in the body and those that do not. During GVHD, the graft sends out lymphocytes to attack your child’s organs and tissues. The new stem cells can damage organs such as the liver, skin or bowel.<br></p><p>Receiving stem cells from an unrelated or mismatched HLA donor increases your child’s chances of developing GVHD.</p><p>There are two types of GVHD: acute GVHD and chronic GVHD. Your child may develop one, both or neither.</p><ul><li>If GVHD develops early (often within three months) after transplant, it is called acute GVHD.</li><li>If GVHD develops later after the transplant, it is called chronic GVHD. Compared to the acute form, chronic GVHD can affect many more organs and cause life-long scarring (for example, on the skin).</li></ul> <figure class="asset-c-100"> <span class="asset-image-title">Graft vs. Host Disease (GVHD)</span> <img src="http://assets.aboutkidshealth.ca/akhassets/Graft_vs_Host_Disease_MED_ILL_EN.jpg" alt="" /> <figcaption class="asset-image-caption">GVHD is a common complication that can occur when a child receives a blood and marrow transplant. The donor graft contains many blood cells, including stem cells and lymphocytes, or immune cells. Stem cells will start to make healthy blood cells in the host. If the immune cells recognize your child's tissues as foreign, they attack and damage them. </figcaption> </figure> <h2>Symptoms of acute GVHD</h2><p>Common signs of GVHD include:</p><ul><li>skin rash, usually starts on the palms or feet but may be on the chest or back. In severe cases, the rash may spread to other parts of the body and become redder in colour (similar to sunburn).</li><li><a href="/article?contentid=7&language=English">diarrhea</a></li></ul><p>Signs that GVHD is affecting the liver include:</p><ul><li>yellowing of the skin and eyes (jaundice)</li><li>mild liver tenderness</li><li>increased amounts of a yellow substance the body normally excretes, called bilirubin. The body gets rid of bilirubin through a fluid excreted by the liver, called bile. When there are high levels of bilirubin in the body, the bile is not working properly.</li></ul><h2>Symptoms of chronic GVHD</h2><p>Some of the more common signs of chronic GVHD affect different parts of the body.</p><ul><li>Eyes – dryness, with increased tearing and redness</li><li>Mouth – dryness with ulcers or sores and changes in taste</li><li>Skin – areas of decreased and increased colour, scarring and thickness. This can cause tightness across joints</li><li>Gut – changes in appetite, frequent loose stools, and unable to gain weight</li></ul><h2>Treating GVHD</h2><p>Children who develop GVHD usually take a combination of medicines. Since some of these medicines also prevent GVHD, your child may be given these medicines prior to the transplant. The doctor may increase the dose if your child develops GVHD after the transplant. If your child develops GVHD of the bowel (gut GVHD), the doctor may need to put them on a specialised diet. This diet will help your child’s bowel rest and heal.</p><h3>Prednisone</h3><p> <a href="/Article?contentid=221&language=English">Prednisone</a> helps treat and prevent GVHD by weakening your child’s new immune system. This way, the new immune system has more time to get used to and tolerate your child’s body. These types of drugs are called immunosuppressants. A healthy immune system fights off cells that do not belong in the body, such as bacteria and other tissue it does not recognize. The goal is for your new immune system (transplant) to accept your body, not attack it. This is why prednisone is the first type of drug doctor’s use to treat and prevent your child’s GVHD.</p><p>Your child may need to use prednisone for a long period of time, depending on the severity of the GVHD.</p><h3>Cyclosporine</h3><p>Similar to prednisone, <a href="/Article?contentid=115&language=English"> cyclosporine </a> is an immunosuppressant. It both prevents and treats GVHD. All children who receive stem cells or bone marrow from a donor will start on cyclosporine before their transplant date. During the transplant period, the doctor needs to make sure your child is receiving an adequate amount of cyclosporine. They will check the level of cyclosporine in your child’s blood periodically.</p><p>Your child continues to take cyclosporine for about six months after the transplant. After being discharged from the hospital, a nurse will check your child’s cyclosporine levels every week.</p><h3>Methotrexate</h3><p> <a href="/Article?contentid=185&language=English"> Methotrexate </a> stops the cells from dividing and making new cells. Methotrexate is used to prevent GVHD following bone marrow or stem cell transplant. Children who receive stem cells or bone marrow from a donor may receive three or four doses of a methotrexate. Since this medicine may cause mouth sores, good mouth care is very important.</p><p>For more information, please see <a href="/Article?contentid=1542&language=English">Daily Care</a>.</p><h2>How long will your child have GVHD?</h2><p>If your child gets GVHD during treatment, the disease usually subsides in a month or two. Chronic GVHD often starts more slowly and takes longer to respond to treatment. Depending on your child’s response to the first medication, doctors may need to use other medicines to control chronic GVHD.</p>https://assets.aboutkidshealth.ca/akhassets/Graft_vs_Host_Disease_MED_ILL_EN.jpgGraft-versus-host disease after a blood and marrow transplant

Thank you to our sponsors

AboutKidsHealth is proud to partner with the following sponsors as they support our mission to improve the health and wellbeing of children in Canada and around the world by making accessible health care information available via the internet.